Detalhe da pesquisa
1.
Pipeline Therapies for Gout.
Curr Rheumatol Rep
; 26(3): 69-80, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133712
Mostrar mais
Texto completo
Documentos relacionados
2.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
J Arthroplasty
; 38(11): 2193-2201, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778918
3.
Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201].
J Arthroplasty
; 39(3): 851-852, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049357
4.
What Is Osteoarthritis?
JAMA
; 327(13): 1300, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380583
5.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
Arthritis Rheumatol
; 75(11): 1877-1888, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746897
6.
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
Arthritis Care Res (Hoboken)
; 75(11): 2227-2238, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743767
7.
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Cancers (Basel)
; 14(23)2022 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497316
